These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32953411)

  • 41. An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans.
    Cargnin S; Magnani F; Viana M; Tassorelli C; Mittino D; Cantello R; Sances G; Nappi G; Canonico PL; Genazzani AA; Raffaeli W; Terrazzino S
    J Pain; 2013 Oct; 14(10):1097-106. PubMed ID: 23773341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study.
    Massat I; Souery D; Del-Favero J; Nothen M; Blackwood D; Muir W; Kaneva R; Serretti A; Lorenzi C; Rietschel M; Milanova V; Papadimitriou GN; Dikeos D; Van Broekhoven C; Mendlewicz J
    Mol Psychiatry; 2005 Jun; 10(6):598-605. PubMed ID: 15583702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report.
    Dávila R; Zumárraga M; Basterreche N; Arrúe A; Zamalloa MI; Anguiano JB
    J Affect Disord; 2006 Jun; 92(2-3):277-81. PubMed ID: 16542735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Catechol-O-methyltransferase, dopamine, and sleep-wake regulation.
    Dauvilliers Y; Tafti M; Landolt HP
    Sleep Med Rev; 2015 Aug; 22():47-53. PubMed ID: 25466290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Association analysis between attention-deficit hyperactivity disorder and Val158Met polymorphism of catechol-O-methyltransferase gene].
    Zhang XN; Ruan LM; Le YP; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):322-4. PubMed ID: 12903043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of catechol-O-methyl-transferase polymorphism Val158Met on functional connectivity in healthy young females: a resting EEG study.
    Lee TW; Yu YW; Hong CJ; Tsai SJ; Wu HC; Chen TJ
    Brain Res; 2011 Mar; 1377():21-31. PubMed ID: 21195697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catechol-o-methyltransferase polymorphisms predict opioid consumption in postoperative pain.
    Candiotti KA; Yang Z; Buric D; Arheart K; Zhang Y; Rodriguez Y; Gitlin MC; Carvalho E; Jaraba I; Wang L
    Anesth Analg; 2014 Nov; 119(5):1194-200. PubMed ID: 25185591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition.
    Bosia M; Buonocore M; Bechi M; Stere LM; Silvestri MP; Inguscio E; Spangaro M; Cocchi F; Bianchi L; Guglielmino C; Cavallaro R
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():363-368. PubMed ID: 30790675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia.
    Park TW; Yoon KS; Kim JH; Park WY; Hirvonen A; Kang D
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):299-303. PubMed ID: 12126868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central pain sensitization, COMT Val158Met polymorphism, and emotional factors in fibromyalgia.
    Desmeules J; Chabert J; Rebsamen M; Rapiti E; Piguet V; Besson M; Dayer P; Cedraschi C
    J Pain; 2014 Feb; 15(2):129-35. PubMed ID: 24342707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.
    Lin G; Zhao J; Wu J; Andreevich O R; Zhang WH; Zhang Y; Yu L
    Genet Mol Res; 2013 Dec; 12(4):6442-53. PubMed ID: 24390993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Sullens A; Yolken RH
    Schizophr Res; 2007 Nov; 96(1-3):87-92. PubMed ID: 17601704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders.
    Carrà G; Nicolini G; Crocamo C; Lax A; Amidani F; Bartoli F; Castellano F; Chiorazzi A; Gamba G; Papagno C; Clerici M
    Nord J Psychiatry; 2017 Jul; 71(5):332-339. PubMed ID: 28635556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis.
    Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z
    J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
    Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of catechol-O-methyltransferase Val158Met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR.
    Ruiz-Sanz JI; Aurrekoetxea I; Ruiz del Agua A; Ruiz-Larrea MB
    Mol Cell Probes; 2007 Jun; 21(3):202-7. PubMed ID: 17337160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
    Suzuki M; Mamun MR; Hara K; Ozeki T; Yamada Y; Kadowaki T; Honda H; Yanagihara Y; Ito YM; Kameyama S; Ohta N; Hosoi T; Arai T; Sawabe M; Takeuchi T; Takahashi S; Kitamura T
    Eur Urol; 2005 Nov; 48(5):752-9. PubMed ID: 16126332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between catechol-O-methyltransferase functional polymorphism and male suicide completers.
    Ono H; Shirakawa O; Nushida H; Ueno Y; Maeda K
    Neuropsychopharmacology; 2004 Jul; 29(7):1374-7. PubMed ID: 15127078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic contribution of catechol-O-methyltransferase polymorphism (Val158Met) in children with chronic tension-type headache.
    Fernández-de-las-Peñas C; Ambite-Quesada S; Rivas-Martínez I; Ortega-Santiago R; de-la-Llave-Rincón AI; Fernández-Mayoralas DM; Pareja JA
    Pediatr Res; 2011 Oct; 70(4):395-9. PubMed ID: 21691248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.